TP53 and cancer: p53 was stabilized and activated by treating the cells with the anti-cancer drug 5-fluorouracil (5-FU) (Longley et al., 2003), as p53 levels are normally regulated by MDM2-mediated ubiquitination and proteasomal degradation (Haupt et al., 1997; Kubbutat et al., 1997).